These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prospective treatment in carnitine-acylcarnitine translocase deficiency. Pierre G, Macdonald A, Gray G, Hendriksz C, Preece MA, Chakrapani A. J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264 [Abstract] [Full Text] [Related]
10. [Analysis of four carnitine-acylcarnitine translocase deficiency cases caused by homozygous mutation of SLC25A20 c.199-10T> G]. Fan X, Xie BB, Zhang Q, Yi S, Geng GX, Yang Q, Luo JS, Wang J, Li C, Chen SK, Shen YP. Zhonghua Er Ke Za Zhi; 2018 Jul 02; 56(7):545-549. PubMed ID: 29996190 [Abstract] [Full Text] [Related]
11. Clinical and molecular characteristics of carnitine-acylcarnitine translocase deficiency: Experience with six patients in Guangdong China. Tang C, Liu S, Wu M, Lin S, Lin Y, Su L, Zhang J, Feng Y, Huang Y. Clin Chim Acta; 2019 Aug 02; 495():476-480. PubMed ID: 31108048 [Abstract] [Full Text] [Related]
19. Carnitine-acylcarnitine translocase deficiency. Clinical course of three Saudi children with a severe phenotype. Al-Sannaa NA, Cheriyan GM. Saudi Med J; 2010 Aug 02; 31(8):931-4. PubMed ID: 20714679 [Abstract] [Full Text] [Related]